Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients (vol 73, pg 439, 2010)

被引：0
|
作者：
Moscarelli, Luciano
机构：
来源：
CLINICAL NEPHROLOGY | 2016年 / 86卷 / 05期
关键词：
D O I：
10.5414/CNP86290
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [31] Use of beta blockers, ACE inhibitors, and angiotensin receptor blockers and risk of breast cancer recurrence: A Danish nationwide cohort study
    Sorensen, Gitte Vrelits
    Ganz, Patricia A.
    Cole, Steven W.
    Pedersen, Lars
    Sorensen, Henrik Toft
    Cronin-Fenton, Deirdre P.
    Garne, Jens Peter
    Christiansen, Peer
    Lash, Timothy L.
    Ahern, Thomas P.
    CANCER RESEARCH, 2012, 72
  • [32] ANGIOTENSIN RECEPTOR BLOCKERS PROVIDE BETTER GLOMERULAR FILTRATION RATES THAN ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN KIDNEY TRANSPLANT RECIPIENTS WITH PROTEINURIA
    Ellik, Zeynep Melekoglu
    Sayin, Burak
    Erdogmus, Siyar
    Colak, Turan
    Akdur, Aydincan
    Haberal, Mehmet A.
    TRANSPLANTATION, 2020, 104 (09) : S431 - S431
  • [33] ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus
    Poulter, Neil
    CARDIOLOGY AND THERAPY, 2025,
  • [34] Potential Influence of ACE Inhibitors and Angiotensin Receptor Blockers on Outcome in Patients With Oropharynx Cancer Treated With Radiation Therapy
    Magnuson, W. J.
    Morris, Z.
    Mohindra, P.
    Geye, H.
    Harari, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S516 - S517
  • [35] ACE inhibitors and angiotensin receptor blockers use and breast cancer outcomes in patients treated with neoadjuvant systemic chemotherapy
    Chae, Young Kwang
    Brown, Erika N.
    Lei, Xiudong
    Melhem-Bertrandt, Amal
    Giordano, Sharon Hermes
    Litton, Jennifer Keating
    Hortobagyi, Gabriel N.
    Gonzalez-Angulo, Ana M.
    Gregor, Mariana Chavez-Mac
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Angiotension II receptor blockers: Equal or preferred substitutes for ACE inhibitors? (vol 160, pg 1905, 2000)
    Grossman
    Messerli
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (02) : 300 - 300
  • [37] Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors (vol 6, pg 296, 2004)
    Harman-Boehm, I
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (06): : 379 - 379
  • [38] Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease (vol 135, pg 73, 2001)
    Jafar, TH
    Schmid, CH
    Landa, M
    Giatras, I
    Toto, R
    Remuzzi, G
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (04) : 299 - 299
  • [39] Early Use of Angiotensin-Converting Enzyme Inhibitors (ACEI) and Angiotensin Receptor Blockers (ARB) Is Associated with Severe Hyperkalemia in Kidney Transplant Recipients.
    Lu, L. H.
    Ueda, K.
    Miguel, M.
    Patel, P.
    Warvariv, V.
    Bohannon, L.
    Bry, W.
    Mahanty, H.
    Hassoun, A.
    Katznelson, S.
    Peddi, V. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 374 - 374
  • [40] No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers:: A collaborative transplant study report
    Opelz, Gerhard
    Zeier, Martin
    Laux, Gunter
    Morath, Christian
    Doehler, Bernd
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (11): : 3257 - 3262
12345